CONFERENCE COVERAGE SERIES
American Academy of Neurology: 2013 Annual Meeting
San Diego, CA, USA
16 – 23 March 2013
The ANN conference in San Diego covered such a plethora of topics, from anti-amyloid antibodies to IVIG, that organizers turned to breakout mini-sessions—what one scientist called "the neurological equivalent of speed dating"—to cram them all in.
Quick-and-Early IVIG Therapy: Hints of Promise?
If another small, hopeful trial is to be believed, pooled antibody treatment has the potential to stave off dementia...
Anti-Amyloid Results Show Modest Benefits, Mild Side Effects
Scientists continue to squeeze every last bit of information out of Phase 3 trials for anti-amyloid antibodies solanezumab and bapineuzumab...
Wrapping Up Enrollment, ADNI 2, PPMI Focus on Earlier Disease
The Alzheimer’s Disease Neuroimaging Initiative steering committee gathered to exchange the latest developments in ADNI 2...
Drug Data Dash at AAN Annual Conference
There were so many new data on neurodegenerative disease trials at the recent AAN meeting that organizers crammed some of them into a session of three-minute talks...